Latest News  

Pfizer Files Suit Against J and J over Remicade Contracts

(Reuters)—Drugmaker Pfizer Inc on Wednesday filed a lawsuit against Johnson and Johnson, saying its rival’s contracts with health insurers for blockbuster rheumatoid arthritis drug, Remicade,… [Read More]

Reassuring Data on Cancer Risk with Contemporary RA Drugs

NEW YORK (Reuters Health)—A large Swedish study1 provides reassuring data on the risk of cancer in patients with rheumatoid arthritis (RA) treated with tumor necrosis factor… [Read More]

Inflammatory Spinal Disorders Common in IBD Patients

NEW YORK (Reuters Health)—Ankylosing spondylitis (AS), axial spondyloarthritis (SpA) and inflammatory back pain are common in inflammatory bowel disease (IBD) patients two decades after IBD… [Read More]

Advances in Education for Rheumatology Health Professionals: A Review & an Opportunity

Educational opportunities for health professionals are expanding. At this year’s Annual Meeting, don’t miss a historic joint session from the ARHP and the Canada-based Arthritis Health Professions Association about the advances in and effects of these educational opportunities on rheumatology… [Read More]

State Funding Changes in Spotlight in U.S. Republican Healthcare Bill

WASHINGTON (Reuters)—Republican leaders sought to nail down the final votes needed to pass what U.S. Vice President Mike Pence on Thursday called their “last best… [Read More]

Many Drug Companies Fail to Conduct Timely Safety Checks on Medicines after FDA Approval

(Reuters Health)—In the rush to approve new medicines, the U.S. Food and Drug Administration often requires drug companies to study possible side effects and alternative… [Read More]

View More Latest News »